Skip to content

Application of CT-Linac-Based "All-in-One" One-Stop Radiotherapy in Breast Cancer

Application of CT-Linac-Based "All-in-One" One-Stop Radiotherapy in All-Scenario Breast Cancer Radiotherapy: A Prospective Clinical Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07776301
Enrollment
225
Registered
2026-08-20
Start date
2021-08-27
Completion date
2028-11-27
Last updated
2026-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

This study aims to evaluate and report the clinical adverse events and dosimetric parameters in breast cancer patients undergoing an "all-in-one (AIO)" one-stop, fully automated radiotherapy workflow. By systematically tracking these clinical and physical metrics, we seek to establish a standardized clinical protocol for AIO radiotherapy in breast cancer management.

Interventions

OTHERRadiotherapy procedure

The workflow relies on specialized convolutional neural networks for automated segmentation and dose-prediction auto-planning. These breast cancer models were trained on 285 historical institutional cases spanning radical mastectomy and breast-conserving surgery over five years. Auto-delineated structures include the clinical target volume, regional lymph nodes (if involved), tumor bed (identified by surgical clips), heart, bilateral lungs, unaffected breast, spinal cord, esophagus, thyroid, and affected humeral head. These contours guide dose prediction to generate deliverable tangential arc plans via clinical-goal-guided automated optimization in the treatment planning system. To adapt to the on-couch treatment scenario, models were validated on retrospective data and offline routines to maximize target delineation accuracy and the first-approval rate of auto-plans.

Sponsors

Fudan University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Histologically or pathologically confirmed breast cancer with definitive indications for radiotherapy (preoperative, postoperative, or radical) * ECOG performance status of 0-2 * Able to remain still and supine on the treatment couch for up to 30 minutes * Provision of signed, written informed consent * Able to comply with daily follow-ups and blood sample collections

Exclusion criteria

* Palliative radiotherapy for concurrent distant metastasis * Incomplete or ongoing chemotherapy * Synchronous multiple primary tumors * Current pregnancy or lactation * Prior history of radiotherapy to the ipsilateral breast, chest wall, thorax, or regional lymph nodes * Severe non-malignant comorbidities (e.g., cardiovascular or pulmonary diseases, systemic lupus erythematosus, scleroderma) resulting in a short life expectancy or inability to tolerate radical radiotherapy * Inability or unlikelihood to comply with study follow-up * Inability or unwillingness to provide written informed consent

Design outcomes

Primary

MeasureTime frameDescription
Acute adverse events6 monthsThe incidence and severity of acute adverse event include radiation dermatitis, pruritus, skin pain, radiation esophagitis, and radiation pneumonitis.

Secondary

MeasureTime frameDescription
Accuracy2 monthsAuto-segmentation accuracy was assessed by comparing automatically generated contours against the final physician-approved contours
Success rate2 monthsRecord AIO workflow success rate: online planning one-pass optimization success rate.
Quality of life (QoL)6 monthsQuality of life will be evaluated via standardized QoL scales.
Time efficiency2 monthsThe time efficiency of the workflow was automatically recorded by the system
Full-Workflow Patient Intrafraction Motion2 monthsEvaluated based on geometric deviations between pretreatment image-guided radiotherapy (IGRT), posttreatment imaging, and the baseline simulation CT
Correlation of Patient Metrology with Setup Error and Dosimetric Performance2 monthsEvaluation of how Body Mass Index (BMI) and weight fluctuations correlate with geometric setup errors and in vivo gamma pass rates
Correlation of Anatomical Scale with Setup Error and Dosimetric Performance2 monthsEvaluation of how anatomical scale/breast size correlates with geometric setup errors and in vivo gamma pass rates

Countries

China

Contacts

CONTACTXiaoli Yu, MD, PhD
xiaoliyu@fudan.edu.cn+86-021-64175590
CONTACTXiaofang Wang, MD, PhD
xiaofang0708@yeah.net+86 18017317247

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 21, 2026